Clinical Scorecard: Bayesian Network Meta-Analysis of Palliative Treatments for Malignant Gastric Outlet Obstruction

At a Glance

Key Highlights

• Malignant GOO is associated with nausea, vomiting, inability to tolerate oral intake, progressive malnutrition, and diminished quality of life in advanced disease.
• The Bayesian network meta-analysis compared surgical gastrojejunostomy, endoscopic stenting, and EUS-guided gastroenterostomy for palliation.
• Primary outcomes were clinical success and reintervention; secondary outcomes included adverse events, 30-day mortality, time until oral intake, hospital length of stay, and overall survival.
• The supplied excerpt describes the methods and outcomes but does not provide comparative outcome estimates or treatment rankings.

Guideline-Based Recommendations

Diagnosis

• The supplied excerpt does not provide diagnostic recommendations for malignant GOO.

Management

• The study compared surgical gastrojejunostomy, endoscopic stenting, and EUS-guided gastroenterostomy as palliative approaches; the supplied excerpt does not report comparative results or identify a preferred approach.

Monitoring & Follow-up

• The study assessed clinical success, reintervention, adverse events, 30-day mortality, time until oral intake, hospital length of stay, and overall survival; these are study outcomes, not monitoring recommendations.

Risks

• The source describes surgical gastrojejunostomy as involving surgical morbidity and prolonged recovery.
• The source describes stent dysfunction and subsequent reintervention as limitations of endoscopic stenting.

Patient & Prescribing Data

Eligible studies compared at least two of the three procedures in adults with malignant GOO; the supplied excerpt does not report the total number of participants.

The supplied excerpt contains no medication or dosing information. It describes three procedural approaches and notes trade-offs involving efficacy, durability, safety, and recovery.

Clinical Best Practices

• The study defined clinical success using each study's criteria for restored oral intake and alleviation of obstructive symptoms; definitions varied and were harmonized to a shared clinical construct.
• The primary network included randomized controlled trials and eligible comparative cohort studies; prespecified randomized-trial-only sensitivity analyses and study-design subgroup analyses assessed robustness.
• The supplied excerpt does not establish a preferred procedure or provide patient-level selection criteria.

Related Resources & Content